CytoMed Therapeutics Ltd (GDTC) stock
GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.78+0.01 (+1.18%)
Close on Nov 17, 2026Market cap $9.26MP/E –Yield –
CytoMed Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
CytoMed Therapeutics's enterprise value was $8.86M on Nov 11, 2026, against $18.00M a year earlier. Over the last 4 years it ranged from $6.01M to $40.79M, with a median of $20.62M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $8.86M | -27.1% |
| 2025 | Dec 31, 2025 | $12.15M | -65.3% |
| 2024 | Dec 31, 2024 | $34.97M | -14.3% |
| 2023 | Dec 29, 2023 | $40.79M | – |
See a number that looks wrong?